Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A panel of experts, sponsored by Merck Sharp & Dohme Ltd and Schering-Plough Ltd and made up of cardiologists, lipidologists, general practitioners and nurses with a special interest in coronary heart disease and lipid management, met recently to debate whether individuals with hyperlipidaemia are being treated to effective levels and, if not, how current and future treatment options could be better employed to reduce cardiovascular risk.


Journal article


British Journal of Cardiology

Publication Date